by Truveta staff | May 8, 2025 | News
With more than 7 million oncology patient journeys spanning more than 100 cancer types, Truveta is leading a new era in cancer research, delivering an unprecedented breadth of regulatory grade data to support researchers in accelerating oncology therapy adoption and...
by Truveta staff | Apr 15, 2025 | Research, Research Insights
Truveta Research explored the monthly trends in the incidence of syphilis among US adults from January 2017 and October 2024. During the early months of the COVID-19 pandemic, the rate of syphilis incidence (e.g., new infection) increased significantly, reaching a...
by Truveta Research | Apr 3, 2025 | Research, Research Insights
The vaccination rate by age six fluctuated between 2018 and 2021; however, rates have decreased since 2021. The rate in 2021 was 81.9% compared to 80.4% in 2024. This means for every 70 children, roughly one more child received two measles vaccines in 2021 compared to...
by Terry Myerson, CEO | Mar 27, 2025 | News
At Truveta, our mission is Saving Lives with Data, and we are thinking about the HHS leadership mission of making American’s healthier, and how to help the talented scientists of HHS do more with less. We’d like to contribute to this important mission – starting...
by Truveta News | Feb 13, 2025 | Data
Truveta Data has now expanded to include new commercial, Medicare, and Medicaid closed claims on more than 200 million patients, linked with electronic health record (EHR) data for more than 120 million patients already part of Truveta Data. Truveta Data now provides...
